YRIDENCE
LIVE

Serial Number

79269976

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 27, 2019

Add to watchlist:

No watchlists yet
View on USPTO

YRIDENCE Trademark

Serial Number: 79269976 • Registration: 6015956

YRIDENCE is a trademark filed by NOVARTIS AG on August 27, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 27, 2019

Registration Date

March 24, 2020

Published for Opposition

January 7, 2020

Cancellation Date

August 6, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION PROCESSED BY IB
Jul 4, 2022 GPNX
INTERNATIONAL REGISTRATION RENEWED
Dec 20, 2021 RNWL
NOTIFICATION PROCESSED BY IB
Dec 12, 2021 GPNX
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 24, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Aug 24, 2021 DETH
NOTIFICATION PROCESSED BY IB
Jun 5, 2020 GPNX
NOTIFICATION PROCESSED BY IB
May 29, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
May 4, 2020 FICS
FINAL DISPOSITION PROCESSED
May 3, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Apr 23, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2019 CNSA
ASSIGNED TO EXAMINER
Nov 26, 2019 DOCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 22, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 22, 2019 REAP
APPLICATION FILING RECEIPT MAILED
Oct 26, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 22, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 21, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 17, 2019 SDRC